abstract |
Methods for the treatment of cellnproliferation disorders, viral infections, andnother conditions without causing significantnside effects normally associated withninterferon therapy, involving administering tona patient in need thereof a therapeuticallyneffective amount of consensus human leukocyteninterferon are disclosed. Also disclosed arenpharmaceutical compositions of consensus humannleukocyte interferon. |